本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

29.73
+0.29000.99%
成交量:69.27萬
成交額:2,055.34萬
市值:34.18億
市盈率:-17.27
高:30.47
開:29.04
低:29.04
收:29.44
52周最高:42.00
52周最低:14.06
股本:1.15億
流通股本:6,472.04萬
量比:1.26
換手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-1.7211
每股收益(LYR):-1.7211
淨資產收益率:-28.29%
總資產收益率:-17.27%
市淨率:5.00
市盈率(LYR):-17.27

資料載入中...

2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities